Trial Profile
Efficacy of treosulfan based conditioning regimen prior to allogenic stem cell trasplantation in patients with acute myelogenous leukemia- from the EBMT registry
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Oct 2014
Price :
$35
*
At a glance
- Drugs Treosulfan (Primary) ; Clofarabine; Cyclophosphamide; Cytarabine; Etoposide; Fludarabine; Melphalan
- Indications Acute myeloid leukaemia; Bone marrow transplant rejection
- Focus Therapeutic Use
- 15 Oct 2014 New trial record